In this webinar, experts Ryan Subhan and Emily Phillips highlight the critical need for early planning and market education in launching rare disease therapies. They discuss strategies for overcoming challenges like genetic testing, diagnosis codes, market shaping, and specialty pharmacy coordination. Emphasizing collaboration, they stress the importance of providing tailored patient support and ensuring easy access to therapy.
Presenters
More Expert Conversation Videos
Special Considerations for First-to-Market (VIDEO)
The video highlights the crucial role of advocacy groups and the importance of early, strategic planning for successfully launching rare disease treatments.
Rare Disease Product Launch Limited Budget (VIDEO)
This video highlights the challenges of launching an expensive therapy for a rare disease, focusing on partnerships, planning, and tailored care.
